ISTA Pharmaceuticals Reveals Positive Results From Phase IIb Clinical Study

ISTA Pharmaceuticals, Inc. announced positive results from its Phase IIb clinical study of ecabet sodium, which is being developed as a treatment for dry eye disease.
RTTNews